TORONTO--(BUSINESS WIRE)-- Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today announced the approval of Clareon® PanOptix® Pro intraocular lens ...
Alcon Inc. ALC recently introduced the Clareon PanOptix Pro intraocular lens (IOL) for cataract patients in the United States. PanOptix Pro leverages proprietary ENLIGHTEN NXT Optical technology to ...
Please provide your email address to receive an email when new articles are posted on . The lens will launch in the U.S. in May. It is designed to provide more uninterrupted light distribution and ...
Please provide your email address to receive an email when new articles are posted on . In the U.S. market, we currently have three newer multifocal IOLs approved for use: the Alcon Clareon PanOptix ...
Alcon Inc. (NYSE:ALC) is one of the 11 Best 52-Week Low Stocks to Buy Right Now. On June 20, Alcon Inc. (NYSE:ALC) announced the approval of the Clareon PanOptix Pro intraocular lens for patients in ...
SEOUL, SOUTH KOREA, May 29, 2026 /EINPresswire.com/ — Dr. Chung Eui Sang, Chief Director of SNU Eye Clinic in Korea, recently served as moderator at the “Clareon ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results